Arianna R. Moreno

Arianna R. Moreno

Auto-generated profile, based on publicly available information

Arianna R. Moreno

Department of Emergency Medicine Brooke Army Medical Center San Antonio Texas USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2019 in Telemedicine and e-Health
Verified
Journal Article
Closed access
RGRajan R. Gadhia
Rajan R. Gadhia
LSLee H. Schwamm
Lee H. Schwamm
AVAnand Viswanathan
Anand Viswanathan
CWCynthia Whitney
Cynthia Whitney
AMArianna Moreno
Arianna Moreno
KZKori S. Zachrison
Kori S. Zachrison
Background/Introduction: Implementation of telestroke has been associated with improved thrombolysis rates and clinical outcomes in remote or neurologically underserved spoke hospitals. Yet, the experience of spoke hospitals using telestroke has not been well described. We sought to characterize spoke hospitals' perceptions of telestroke to understand perceived advantages, challenges, and barriers to use. Design/Methods: Within our northeastern US telestroke network, we conducted scripted interviews with representatives (stroke coordinators, nurse managers, and emergency physicians) from each of the 15 spoke hospitals connected to a single academic hub hospital. Interview questions included both open-ended and Likert scale responses. We used descriptive and nonparametric analyses (e.g., logit) to present the results. Results: Of the 15 spoke hospitals interviewed, the majority felt that telestroke enabled them to treat more patients with the tissue plasminogen activator (tPA; 93.3%, n  = 14) and to achieve faster door-to-needle times for tPA treatment (80%, n  = 12). Higher Likert scores were not correlated with hospitals' consult volume or tPA volume. The most commonly reported barriers to using telestroke were providers who were not familiar or comfortable using the technology (66%, n  = 10). Few hospitals had concerns that telestroke led to overtreatment with tPA (13.3%, n  = 2) or led to unnecessary transfers (20%, n  = 3). None of the hospitals felt that the physician–patient relationship was compromised, nor was there a concern that patients would have a negative perception of the spoke hospital with utilization of services. Conclusions: Within this single hub–spoke telestroke system in the northeast, we found that spoke hospitals perceive the advantages of telestroke to be in enabling improved rates and efficiency of tPA administration. Barriers to use were most often related to technological challenges rather than concerns about patient care or patients' perceptions. Future work should further explore how to better meet the needs of spoke hospitals in caring for stroke patients.

15 November 2024 in Critical Care Medicine
Verified
Journal Article
Closed access
AMArianna R. Moreno
Arianna R. Moreno
AFAndrew D. Md Fisher
Andrew D. Md Fisher
BLBrit J. Long
Brit J. Long
DDDavid J. Douin
David J. Douin
FWFranklin L. Wright
Franklin L. Wright
SSSteven Schauer
Steven Schauer
OBJECTIVES: To determine the association of whole blood and other blood products (components, prothrombin complex concentrate, and fibrinogen concentrate) with the development of acute respiratory distress syndrome (ARDS) among blood recipients. DESIGN: Retrospective cohort study. SETTING: American College of Surgeons Trauma Quality Improvement Program (TQIP) database between 2020 and 2021. PATIENTS: Patients 15 years old or older in the TQIP database between 2020 and 2022 who received at least one blood product. INTERVENTIONS: We compared characteristics and blood product administration between patients who developed ARDS versus those who did not. MEASUREMENTS AND MAIN RESULTS: There were 134,863 that met inclusion for this analysis. Within the included population, 1% (1927) was diagnosed with ARDS. The no ARDS group had a lower portion of serious injuries to the head/neck (31% vs. 46%), thorax (51% vs. 78%), abdomen (34% vs. 48%), and extremities (37% vs. 47%). The median composite Injury Severity Score was 21 (11–30) in the no ARDS group vs. 30 (22–41) in the ARDS group. Unadjusted survival of discharge was 74% in the no ARDS group vs. 61% in the ARDS group. In our multivariable model, we found that whole blood (unit odds ratio [uOR], 1.05; 95% CI, 1.02–1.07), male sex (odds ratio, 1.44; 95% CI, 1.28–1.63), arrival shock index (uOR, 1.03; 95% CI, 1.01–1.06), and composite Injury Severity Score (uOR, 1.03; 95% CI, 1.03–1.04) were associated with the development of ARDS. These persisted on sensitivity testing. CONCLUSIONS: We found an association between whole blood and the development of ARDS among trauma patients who received blood transfusions. Contrary to previous studies, we found no association between ARDS and fresh frozen plasma administration. The literature would benefit from further investigation via prospective study designs.

17 December 2025 in AEM Education and Training
Verified
Journal Article
Closed access
AMArianna R. Moreno
Arianna R. Moreno
RPR. Madelaine Paredes
R. Madelaine Paredes
AMAllyson Araña Mireles
Allyson Araña Mireles
JCJae‐Hyek Choi
Jae‐Hyek Choi
HSHeang Sundermann
Heang Sundermann
JMJoseph K. Maddry
Joseph K. Maddry